Press
Back to Press

Dr. Jorge Cortes Joins Dr. Andre Goy and Dr. Sagar Lonial as Co-Chair for the Landmark Physicians' Education Resource® International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Also known as Winter Hematology, and formerly referred to as “The Whistler Meeting” when in Whistler, Canada, this long-standing PER legacy congress is a premier event for treating hematologic malignancies

CRANBURY, N.J.--Physicians’ Education Resource® (PER®), the leading resource for oncology and hematology continuing medical education (CME), adds Jorge Cortes, MD to the list of renowned chairs for the 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma that is taking place March 2-4, 2018 in Miami, Florida. This historic legacy conference, often referred to as simply Winter Hematology®, has been a flagship CME conference for over two decades.

Phil Talamo, president of PER® said, “With the addition of Dr. Cortes to our premier faculty of co-chairs, this year’s meeting will be one of the most impactful, as we will share clinical data breaks and emerging treatments of hematologic malignancies.”

Dr. Cortes, Jane and John Justin Distinguished Chair in Leukemia Research, chief, CML & AML Sections, deputy chair, Department of Leukemia, The University of Texas MD Anderson Cancer Center; will be joined by Andre H. Goy, MD, executive director John Theurer Cancer Center, director of oncology for Hackensack Meridian Health, Lydia Pfund Chair for Lymphoma, chair oncology Seton Hall University, professor of medicine, Georgetown University, Washington DC; and Sagar Lonial, MD, FACP, professor, Emory School of Medicine, chair, Department of Hematology and Medical Oncology, chief medical officer, Winship Cancer Institute of Emory University, Atlanta, Georgia.

The annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma is a three-day, interactive and engaging conference that will focus on topics associated with leukemia, lymphoma and myeloma. The expert co-chairs will be joined be a renowned faculty from Harvard Medical School and The University of Texas MD Anderson Cancer Center. Attendees are encouraged to socialize with their peers and discuss the evolving clinical strategies that can be implemented in clinical practice settings.

For registration and more information, visit http://www.gotoper.com/conferences/hem/meetings/22nd-international-congress-on-hematologic-malignancies-focus-on-leukemias-lymphomas-and-myeloma.

About PER®:

Since 1995, PER® has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Unites States and Europe, along with many world renown online learning formats. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology®, is accredited the Council for Continuing Medical Education and the California Board of Registered Nursing. PER®, is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

Contacts
PER® Media:

Theresa Burek
tburek@mjhassoc.com
or
Surabhi Verma
sverma@mjhassoc.com


Back to Press








Become a Member

Forgot Password?
Filter By